Proteomic studies of B16 lines: Involvement of Annexin A1 in melanoma dissemination

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 1, 2009, Pages 61-69

  Rondepierre, Fabien ^a   Bouchon, Bernadette ^a   Papon, Janine ^a   Bonnet Duquennoy, Mathilde ^a   Kintossou, Roselyne ^a   Moins, Nicole ^a   Maublant, Jean ^a   Madelmont, Jean C ^a   D'Incan, Michel ^a   Degoul, Françoise ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Annexin A1; Formyl peptide receptor; Invasion; Melanoma; Metastasis

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 2; BETA ACTIN; CARBONATE DEHYDRATASE; CARBOXYLESTERASE; CREATINE KINASE BB; FATTY ACID BINDING PROTEIN; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; GLUTATHIONE TRANSFERASE A4; LACTATE DEHYDROGENASE; LIPOCORTIN 1; LIPOCORTIN 4; MATRIGEL; ORNITHINE OXOACID AMINOTRANSFERASE; PROTEIN INHIBITOR; PROTEIN P57; SMALL INTERFERING RNA; TUMOR PROTEIN; VALOSIN CONTAINING PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; DETOXIFICATION; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; ENERGY YIELD; GENETIC VARIABILITY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOMA; MELANOMA B16; METASTASIS; MODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANNEXIN A1; BASE SEQUENCE; CELL LINE, TUMOR; CREATINE KINASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM METASTASIS; PROTEOMICS; RECEPTORS, FORMYL PEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR CELLS, CULTURED;

MUS;

EID: 56449115574     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.09.014     Document Type: Article

References (62)

1. Garbe C., and Eigentler T.K. Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Res. 17 (2007) 117-127
2. Gaggioli C., and Sahai E. Melanoma invasion - current knowledge and future directions. Pigment Cell Res. 20 (2007) 161-172
3. Boukerche H., Su Z.Z., Emdad L., Baril P., Balme B., Thomas L., Randolph A., Valerie K., Sarkar D., and Fisher P.B. mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res. 65 (2005) 10901-10911
4. Boukerche H., Su Z.Z., Emdad L., Sarkar D., and Fisher P.B. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res. 67 (2007) 1812-1822
5. Zhou Y., Dai D.L., Martinka M., Su M., Zhang Y., Campos E.I., Dorocicz I., Tang L., Huntsman D., Nelson C., Ho V., and Li G. Osteopontin expression correlates with melanoma invasion. J. Invest. Dermatol. 124 (2005) 1044-1052
6. Robert G., Gaggioli C., Bailet O., Chavey C., Abbe P., Aberdam E., Sabatie E., Cano A., Garcia de Herreros A., Ballotti R., and Tartare-Deckert S. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res. 66 (2006) 7516-7523
7. Alonso S.R., Tracey L., Ortiz P., Perez-Gomez B., Palacios J., Pollan M., Linares J., Serrano S., Saez-Castillo A.I., Sanchez L., Pajares R., Sanchez-Aguilera A., Artiga M.J., Piris M.A., and Rodriguez-Peralto J.L. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res. 67 (2007) 3450-3460
8. Smit D.J., Gardiner B.B., and Sturm R.A. Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype. Int. J. Cancer 121 (2007) 2653-2660
9. Poste G., Doll J., Hart I.R., and Fidler I.J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 40 (1980) 1636-1644
10. Ishiguro T., Nakajima M., Naito M., Muto T., and Tsuruo T. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res. 56 (1996) 875-879
11. Taniguchi S., Kawano T., Kakunaga T., and Baba T. Differences in expression of a variant actin between low and high metastatic B16 melanoma. J. Biol. Chem. 261 (1986) 6100-6106
12. Shimokawa-Kuroki R., Sadano H., and Taniguchi S. A variant actin (beta m) reduces metastasis of mouse B16 melanoma. Int. J. Cancer 56 (1994) 689-697
13. Ito A., Koma Y., Watabe K., Nagano T., Endo Y., Nojima H., and Kitamura Y. A truncated isoform of the protein phosphatase 2A B56gamma regulatory subunit may promote genetic instability and cause tumor progression. Am. J. Pathol. 162 (2003) 81-91
14. Hirata F., Schiffmann E., Venkatasubramanian K., Salomon D., and Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 2533-2536
15. Flower R.J. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol. 94 (1988) 987-1015
16. Kim K.M., Kim D.K., Park Y.M., Kim C.K., and Na D.S. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett. 343 (1994) 251-255
17. Lim L.H., and Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J. 21 (2007) 968-975
18. Buchdahl C., Papon J., Communal Y., Bourges M., and Madelmont J.C. G2 accumulation and melanin overproduction in malignant melanocytes treated with a new nitrosourea. Melanoma Res. 8 (1998) 517-527
19. Bouchon B., Chambon C., Mounetou E., Papon J., Miot-Noirault E., Gaudreault R.C., Madelmont J.C., and Degoul F. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter. Mol. Pharmacol. 68 (2005) 1415-1422
20. Ando Y., Imamura S., Hong Y.M., Owada M.K., Kakunaga T., and Kannagi R. Enhancement of calcium sensitivity of lipocortin I in phospholipid binding induced by limited proteolysis and phosphorylation at the amino terminus as analyzed by phospholipid affinity column chromatography. J. Biol. Chem. 264 (1989) 6948-6955
21. Alldridge L.C., and Bryant C.E. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp. Cell Res. 290 (2003) 93-107
22. Mancuso F., Flower R.J., and Perretti M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J. Immunol. 155 (1995) 377-386
23. Perretti M., Croxtall J.D., Wheller S.K., Goulding N.J., Hannon R., and Flower R.J. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med. 2 (1996) 1259-1262
24. Getting S.J., Flower R.J., and Perretti M. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br. J. Pharmacol. 120 (1997) 1075-1082
25. Solito E., Romero I.A., Marullo S., Russo-Marie F., and Weksler B.B. Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. J. Immunol. 165 (2000) 1573-1581
26. Babbin B.A., Lee W.Y., Parkos C.A., Winfree L.M., Akyildiz A., Perretti M., and Nusrat A. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J. Biol. Chem. 281 (2006) 19588-19599
27. Bini L., Magi B., Marzocchi B., Arcuri F., Tripodi S., Cintorino M., Sanchez J.C., Frutiger S., Hughes G., Pallini V., Hochstrasser D.F., and Tosi P. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18 (1997) 2832-2841
28. Reymond M.A., Sanchez J.C., Hughes G.J., Gunther K., Riese J., Tortola S., Peinado M.A., Kirchner T., Hohenberger W., Hochstrasser D.F., and Kockerling F. Standardized characterization of gene expression in human colorectal epithelium by two-dimensional electrophoresis. Electrophoresis 18 (1997) 2842-2848
29. Cui J.F., Liu Y.K., Pan B.S., Song H.Y., Zhang Y., Sun R.X., Chen J., Feng J.T., Tang Z.Y., Yu Y.L., Shen H.L., and Yang P.Y. Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J. Cancer Res. Clin. Oncol. 130 (2004) 615-622
30. Zimmermann U., Balabanov S., Giebel J., Teller S., Junker H., Schmoll D., Protzel C., Scharf C., Kleist B., and Walther R. Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett. 209 (2004) 111-118
31. Munz M., Zeidler R., and Gires O. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP. Cancer Lett. 225 (2005) 151-157
32. Wang G., Shang L., Burgett A.W., Harran P.G., and Wang X. Diazonamide toxins reveal an unexpected function for ornithine delta-amino transferase in mitotic cell division. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2068-2073
33. Williams N.S., Burgett A.W., Atkins A.S., Wang X., Harran P.G., and McKnight S.L. Therapeutic anticancer efficacy of a synthetic diazonamide analog in the absence of overt toxicity. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 2074-2079
34. Stierum R., Gaspari M., Dommels Y., Ouatas T., Pluk H., Jespersen S., Vogels J., Verhoeckx K., Groten J., and van Ommen B. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim. Biophys. Acta 1650 (2003) 73-91
35. Yamazaki D., Kurisu S., and Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96 (2005) 379-386
36. Huddleston H.G., Wong K.K., Welch W.R., Berkowitz R.S., and Mok S.C. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol. Oncol. 96 (2005) 77-83
37. Joseph J., Cardesa A., and Carreras J. Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas. Br. J. Cancer 76 (1997) 600-605
38. Balasubramani M., Day B.W., Schoen R.E., and Getzenberg R.H. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Cancer Res. 66 (2006) 763-769
39. Bai X.F., Ni X.G., Zhao P., Liu S.M., Wang H.X., Guo B., Zhou L.P., Liu F., Zhang J.S., Wang K., Xie Y.Q., Shao Y.F., and Zhao X.H. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 10 (2004) 1466-1470
40. Lopez-Pedrera C., Villalba J.M., Siendones E., Barbarroja N., Gomez-Diaz C., Rodriguez-Ariza A., Buendia P., Torres A., and Velasco F. Proteomic analysis of acute myeloid leukemia: identification of potential early biomarkers and therapeutic targets. Proteomics 6 Suppl 1 (2006) S293-S299
41. Shen D., Nooraie F., Elshimali Y., Lonsberry V., He J., Bose S., Chia D., Seligson D., Chang H.R., and Goodglick L. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol. 37 (2006) 1583-1591
42. Silistino-Souza R., Rodrigues-Lisoni F.C., Cury P.M., Maniglia J.V., Raposo L.S., Tajara E.H., Christian H.C., and Oliani S.M. Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int. J. Cancer 120 (2007) 2582-2589
43. Sakaguchi M., Murata H., Sonegawa H., Sakaguchi Y., Futami J., Kitazoe M., Yamada H., and Huh N.H. Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. J. Biol. Chem. 282 (2007) 35679-35686
44. Rescher U., Danielczyk A., Markoff A., and Gerke V. Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J. Immunol. 169 (2002) 1500-1504
45. Walther A., Riehemann K., and Gerke V. A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell 5 (2000) 831-840
46. Andersen K., Nesland J.M., Holm R., Florenes V.A., Fodstad O., and Maelandsmo G.M. Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma. Mod. Pathol. 17 (2004) 990-997
47. Zhou Y., Bian X., Le Y., Gong W., Hu J., Zhang X., Wang L., Iribarren P., Salcedo R., Howard O.M., Farrar W., and Wang J.M. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J. Natl. Cancer Inst. 97 (2005) 823-835
48. Solito E., Christian H.C., Festa M., Mulla A., Tierney T., Flower R.J., and Buckingham J.C. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J 20 (2006) 1498-1500
49. Castro-Caldas M., Duarte C.B., Carvalho A.P., and Lopes M.C. Dexamethasone induces the secretion of annexin I in immature lymphoblastic cells by a calcium-dependent mechanism. Mol. Cell Biochem. 237 (2002) 31-38
50. Movitz C., Sjolin C., and Dahlgren C. Cleavage of annexin I in human neutrophils is mediated by a membrane-localized metalloprotease. Biochim. Biophys. Acta 1416 (1999) 101-108
51. Summers T.A., and Creutz C.E. Phosphorylation of a chromaffin granule-binding protein by protein kinase C. J. Biol. Chem. 260 (1985) 2437-2443
52. Dorovkov M.V., and Ryazanov A.G. Phosphorylation of annexin I by TRPM7 channel-kinase. J. Biol. Chem. 279 (2004) 50643-50646
53. Fava R.A., and Cohen S. Isolation of a calcium-dependent 35-kilodalton substrate for the epidermal growth factor receptor/kinase from A-431 cells. J. Biol. Chem. 259 (1984) 2636-2645
54. Pepinsky R.B., and Sinclair L.K. Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 321 (1986) 81-84
55. de Wit P.E., Moretti S., Koenders P.G., Weterman M.A., van Muijen G.N., Gianotti B., and Ruiter D.J. Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. J. Invest. Dermatol. 99 (1992) 168-173
56. Sparrow L.E., and Heenan P.J. Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization. Australas J. Dermatol. 40 (1999) 19-24
57. Rakosy Z., Vizkeleti L., Ecsedi S., Voko Z., Begany A., Barok M., Krekk Z., Gallai M., Szentirmay Z., Adany R., and Balazs M. EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis. Int. J. Cancer 121 (2007) 1729-1737
58. Huang J., Hu J., Bian X., Chen K., Gong W., Dunlop N.M., Howard O.M., and Wang J.M. Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res. 67 (2007) 5906-5913
59. Rhee H.J., Kim G.Y., Huh J.W., Kim S.W., and Na D.S. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur. J. Biochem. 267 (2000) 3220-3225
60. Kim Y.S., Ko J., Kim I.S., Jang S.W., Sung H.J., Lee H.J., Lee S.Y., Kim Y., and Na D.S. PKCdelta-dependent cleavage and nuclear translocation of annexin A1 by phorbol 12-myristate 13-acetate. Eur. J. Biochem. 270 (2003) 4089-4094
61. Liu Y., Wang H.X., Lu N., Mao Y.S., Liu F., Wang Y., Zhang H.R., Wang K., Wu M., and Zhao X.H. Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma. World J. Gastroenterol. 9 (2003) 645-649
62. Lin C.Y., Jeng Y.M., Chou H.Y., Hsu H.C., Yuan R.H., Chiang C.P., and Kuo M.Y. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J. Surg. Oncol. 97 (2008) 544-550